Johnson Pharma

Not Rated
  • Market Cap: Micro Cap
  • Industry: Diversified Commercial Services
  • ISIN: INE560F01022
  • NSEID:
  • BSEID: 532154
INR
0.59
-0.01 (-1.67%)
BSENSE

Dec 24

BSE+NSE Vol: 8.51 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Mar'18
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2023 is -22.56% vs 329.37% in Mar 2022

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2023 is -1,086.27% vs 8,388.78% in Mar 2022

stock-summary

Interest

YoY Growth in year ended Mar 2023 is 166.67% vs 0.00% in Mar 2022

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2023 is -1,435.47% vs 8,135.39% in Mar 2022

Compare Profit and Loss Results of Johnson Pharma
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
2.00
5.00
-3.00
-60.00%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
2.00
5.00
-3.00
-60.00%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
2.00
0.00
2.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
0.00
0.00
0%
Operating Expenses
0.00
0.00
0.00
0%
General and Administration Expenses
-1.00
0.00
-1.00
0%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
1.00
0.00
1.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
3.00
1.00
2.00
200.00%
Operating Profit (PBDIT) excl Other Income
-1.00
4.00
-5.00
-125.00%
Other Income
0.00
0.00
0.00
0%
Operating Profit (PBDIT)
-1.00
4.00
-5.00
-125.00%
Interest
0.00
2.00
-2.00
-100.00%
Profit before Depriciation and Tax
-1.00
1.00
-2.00
-200.00%
Depreciation
0.00
0.00
0.00
0%
Profit Before Taxation & Exceptional Items
-1.00
1.00
-2.00
-200.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
-1.00
1.00
-2.00
-200.00%
Provision for Tax
0.00
0.00
0.00
0%
Profit After Tax
-1.00
0.00
-1.00
0%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
-1.00
6.00
-7.00
-116.67%
Profit Available for appropriations
-2.00
7.00
-9.00
-128.57%
Appropriations
-2.00
7.00
-9.00
-128.57%
Equity Dividend (%)
0%
15%
-15.00
Earnings Per Share
-0.02
1.5
-1.52
-101.33%
Profit And Loss - Net Sales
Net Sales 2.53 Cr
in Mar 2023

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2023 is -22.56% vs 329.37% in Mar 2022

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) -1.33 Cr
in Mar 2023

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2023 is -1,086.27% vs 8,388.78% in Mar 2022

Profit And Loss - Interest
Interest 0.00 Cr
in Mar 2023

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2023 is 166.67% vs 0.00% in Mar 2022

Profit And Loss - Profit After Tax
Profit After Tax -1.29 Cr
in Mar 2023

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2023 is -1,435.47% vs 8,135.39% in Mar 2022